Detailed price information for Theralase Technologies Inc (TLTFF) from The Globe and Mail including charting and trades.
Theralase Technologies (TSXV:TLT), a pharmaceutical stock focused treating a diversity of unmet needs, demonstrated that its ...
In the latest Theralase® research, Balb/C mice were infected with human HSV-1 virus. On day 6 post-infection, 20 uL of 1% Ruvidar® solution was applied topically over the area of well-developed ...
In this detailed study, Cohen and Ben-Shaul characterized Accessory Olfactory Bulb (AOB) cell responses to various conspecific urine samples in female mice across the estrous cycle. The authors found ...
Merwin, R. M., and Algire, G. H., Proc. Soc. Exp. Biol. and Med., 101, 437 (1959).
(c) Ratio of protein to oseltamivir binding (mg/ml)/(mg/ml). (d) Groups of 5 female BALB/c mice were immunized in a prime-boost regimen in a 2 weeks interval with AF03-adjuvanted N1 NAs. Homologous ...
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...
Mouse cells tweaked to produce the tardigrade protein incurred less DNA damage than unaltered cells — hinting at a new tool for cancer patient care.
This site uses cookies to enhance your user experience. By continuing to use this site you are agreeing to our COOKIE POLICY.
Musk calls it ‘demented’ research Elon Musk recently criticized such experiments in an episode of the Joe Rogan Experience podcast, calling them a “horror show” and accusing researchers of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results